Stephen Basso
Direttore Finanziario/CFO presso INNOVIVA, INC.
Posizioni attive di Stephen Basso
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INNOVIVA, INC. | Direttore Finanziario/CFO | 21/08/2023 | - |
Storia della carriera di Stephen Basso
Precedenti posizioni note di Stephen Basso
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INOZYME PHARMA, INC. | Comptroller/Controller/Auditor | 01/10/2017 | 14/05/2021 |
| Direttore Finanziario/CFO | 01/10/2017 | 14/05/2021 | |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2009 | 01/05/2017 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Direttore operativo | - | - |
| Direttore Finanziario/CFO | - | - |
Formazione di Stephen Basso
| Boston College | Masters Business Admin |
| Providence College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Director of Finance/CFO | 3 |
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Stephen Basso
- Esperienza
